CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity

Seminars in Immunology

Volumn 10, Issue 6, 1998, Pages 443-448

  Toes, René E M ^a,b   Schoenberger, Stephen P ^c   Van Der Voort, Ellen I H ^a   Offringa, Rienk ^a   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute für Zellbiologie   (Germany)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD40; Cross priming; Cytotoxic T lymphocyte; Dendritic eels; T helper cell

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN GP 39; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNE RESPONSE; MULTIGENE FAMILY; NONHUMAN; RECEPTOR GENE;

EID: 17744418516     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0147     Document Type: Article

References (44)

1. 1. Allison JP (1994) CD28-B7 interactions in T cell activation. Curr Opin Immunol 6:414-419
2. + T cells by B7-transfected melanoma cells. Science 259:368-370
3. 3. Bevan MJ (1976) Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143:1283-1288
4. 4. Matzinger P, Bevan M (1977) Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol 33:92-100
5. + T cells to an antigen that no longer serves as a target. J Exp Med 178:933-940
6. 6. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-965
7. 7. Tzy-Choo WU, Huang AYC, Jaffee EM, Levitsky HI, Pardoll DM (1995) A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med 182:1415-1421
8. 8. Toes REM, Blom RJJ, van der Voort E, Offringa R, Melief CJM, Kast WM (1996) Protective anti-tumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res 56:3782-3783
9. 9. Doe B, Selby M, Barnett S, Baenziger J, Walker CM (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone-marrow cells. Proc Natl Acad Sci USA 93:8578-8583
10. 10. Huang AY, Bruce AT, Pardoll DW, Levitsky HI (1996) Does B7-1 expression confer antigen-processing cell capacity to tumors in vivo? J Exp Med 183:769-776
11. 11. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H (1996) Constitutive class I-restricted exogenous presentation of self-antigens in vivo. J Exp Med 184:923-930
12. + T cells. J Exp Med 186:239-245
13. + T cell help. J Exp Med 186:65-70
14. 14. Guerder S, Matzinger P (1992) A fail-safe mechanism for maintaining self-tolerance. J Exp Med 176:553-564
15. a by exposure to alloantigen in the absence of T cell help. Proc Natl Acad Sci USA 87:2765-2769
16. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 186:2057-2062
17. 17. Keene J, Forman J (1982) Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 155:768-782
18. 18. Mitchison NA, O'Malley C (1987) Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and non-cognate requirements of the in vivo cytolytic response. Eur J Immunol 17:1579-1583
19. 19. Cassel D, Forman J (1988) Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes. Ann NY Acad Sci 532:51-60
20. 20. Boog CJP, Kast WM, Timmers HTM, Boes J, de Waal LP, Melief CJM (1985) Abolition of specific immune response defect by immunization with dendritic cells. Nature 318:59-62
21. + T-cell responses. Immunol Today 17(9):410-414
22. 22. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178
23. 23. Renshaw BR, Fanslow WC, Armitage RJ, Campbell KA, Liggitt D, Wright B, Davison BL, Maliszewski CR (1994) Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 180:1889-1900
24. 24. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281
25. 25. Yang Y, Wilson JM (1996) CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862-1864
26. 26. Mackey MF, Gunn JR, Ting P, Kikutani H, Dranoff G, Noelle RJ, Barth Jr, RJ (1997) Protective immunity induced by tumor vaccines requires interactions between CD40 and its ligand, CD154. Cancer Res 57:2569-2574
27. 27. Kiener PA, Moran DP, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation with purified soluble CD40L induces proinflammatory responses in human monocytes. J Immunol 155:4917-4925
28. 28. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184:741-746
29. 29. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747-752
30. 30. Shinde Sea (1996) CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly upregulated by CD40L. J Immunol 157:2764-2768
31. 31. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM (1998) T help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483
32. 32. Toes REM, Offringa R, Blom HJJ, Brandt RMP, Van der Eb AJ, Melief CJM, Kast WM (1995) An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene. J Immunol 154:3396-3405
33. 33. Rolink A, Melchers F, Andersson J (1996) The SCID but not the RAG-2 gene product is required for the S mu-S epsilon heavy chain class switching. Immunity 5:319-330
34. 34. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH (1991) Depletion of CD4 + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417-1420
35. 35. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A (1992) A 39-KDa protein on activated T helper cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89:6550-6554
36. 36. Bennet SRM, Carbone FR, Karamalis F, Flavell RA, Miller JFAP, Heath WR (1998) Help for cytotoxic T cell responses is mediated by CD40 signalling. Nature 393:478-480
37. + T-helper and a T-killer cell. Nature 393:474-478
38. 38. Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, Odermatt B, Hanahan D, Zinkernagel RM, Ohashi PS (1997) Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med 186:645-653.
39. 39. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-787
40. 40. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steiman RM, Mellman I (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-792
41. 41. Billingham RE (1966) The biology of graft-versus-host reactions. Harvey Lect 62:21-78
42. 42. van Bekkum D, Roodenburg J, Heidt P, van der Waaij D (1974) Migration of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 52:401-404
43. 43. Lonnqvist B, Ringden O, Wahren B, Gahrton G, Lundgren G (1984) Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 38:465-468
44. + T cells to cause immunopathology. J Exp Med 187:763-774